NCT00144651View on ClinicalTrials.gov

Study of MRA in Patients With Rheumatoid Arthritis (RA)

PHASE2CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Rheumatoid Arthritis
Interventions
DRUG

MRA(Tocilizumab)

8mg/kg/4 weeks for 1 year

Sponsors
All Listed Sponsors
lead

Chugai Pharmaceutical

INDUSTRY